---
title: "MDA Space PT Raised to C$70 on Strong Q2 Beat, Upgraded Outlook and Robust Backlog"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295261868.md"
description: "Jefferies analyst Sheila Kahyaoglu upgraded MDA Space's price target to C$70 from C$57, maintaining a Buy rating. The upgrade reflects strong Q2 performance with revenue and EBITDA beating estimates, raised full-year guidance, and a robust C$4.0B backlog. Canaccord Genuity also reiterated a Buy rating with a C$65 target."
datetime: "2026-08-07T16:35:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295261868.md)
  - [en](https://longbridge.com/en/news/295261868.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295261868.md)
generator: "portal-rs"
---

# MDA Space PT Raised to C$70 on Strong Q2 Beat, Upgraded Outlook and Robust Backlog

In a report released today, Sheila Kahyaoglu from Jefferies maintained a Buy rating on MDA Space Ltd, with a price target of C$70.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Sheila Kahyaoglu has given his Buy rating due to a combination of factors stemming from MDA Space Ltd.’s strong Q2:26 performance and improved outlook. The company delivered revenue and adjusted EBITDA that substantially exceeded both her estimates and consensus, while narrowing and raising the midpoint of full‑year revenue and profit guidance, which points to solid double‑digit growth and stable margins.

She also highlights the robust C$4.0B backlog and healthy book‑to‑bill ratio, underscoring sustained demand visibility across MDA’s programs. Despite expectations for neutral to slightly negative free cash flow in the near term due to elevated capex and working capital timing, Kahyaoglu views these investments as supporting long‑term growth, and she lifts her price target from C$57 to C$70 to reflect the stronger fundamentals and enhanced earnings power.

In another report released today, Canaccord Genuity also reiterated a Buy rating on the stock with a C$65.00 price target.

### Related Stocks

- [MDA.US](https://longbridge.com/en/quote/MDA.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)

## Related News & Research

- [MDA Space Ltd (MDA) Receives a Buy from Morgan Stanley](https://longbridge.com/en/news/296117319.md)
- [ATB Cormark Capital Markets Remains a Hold on MDA Space Ltd (MDA)](https://longbridge.com/en/news/295414303.md)
- [BioSyent GAAP EPS of C$0.25, revenue of C$19.87M](https://longbridge.com/en/news/296538491.md)
- [Evolve Future Leadership Fund - ETF Hedged declares CAD 0.21 dividend](https://longbridge.com/en/news/296299467.md)
- [Insider Selling: Alvopetro Energy (CVE:ALV) Director Sells 10,200 Shares](https://longbridge.com/en/news/296081468.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**